Melanotan II (MT-2) Quality Validation Guide | Sunrise
Melanotan II,MT-2,CAS 121062-08-6,Synthetic Melanotan II,Melanotan II bulk supply,buy research grade peptides,GMP peptide manufacturer,Melanotan II HPLC purity,MT-2 COA validation,Melanotan II chemical properties,peptide cold-chain logistics
Content
How Can Procurement Managers Validate Melanotan II (MT-2) Quality for Advanced MCR Research in 2026?
Introduction: As the biological evaluation of synthetic peptides undergoes stricter regulatory scrutiny in 2026, establishing verified sourcing pathways for highly specific research chemical reagents has become a critical objective for laboratory procurement networks. Melanotan II (MT-2), a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (α-MSH), stands at the forefront of receptor pharmacology targeting melanocortin receptor pathways. Authored by the technical team at Shaanxi Sunrise Pharma, this evaluation delivers factual, verified data points to facilitate informed enterprise supply chain strategies.
⚠️ Strict Regulatory Compliance Threshold (ICH Q7 Guidelines): Melanotan II manufactured by Shaanxi Sunrise Pharma is intended solely for industrial production, target verification, and laboratory-scale scientific research. This product is explicitly NOT for human clinical application, veterinary deployment, therapeutic use, or dietary integration.
1. How Does Molecular Optimization Enhance Stability?
Through strategic structural recalibration, Melanotan II (MT-2) achieves significant degradation resistance predicated on three key chemical modifications:
N-terminal Acetylation: Acts as a shield against rapid exopeptidase cleavage, maintaining molecular integrity.
C-terminal Amidation: Neutralizes the terminal negative charge, guaranteeing structural stability within neutral buffers.
Cyclic Modification (Positions 4 and 10): Restricts conformational flexibility to ensure high steric alignment with targeted receptor domains.
2. Core Technical Parameters of a Research-Grade Peptide COA
Utilizing multi-stage preparative HPLC, Shaanxi Sunrise Pharma enforces the following strict analytical parameters:
3. Scope of Melanotan II Multi-Target Agonism Applications
▶ MC₁R Activation in Pigment Metabolism
MT-2 specifically interacts with MC₁R expressed on skin melanocytes, elevating tyrosinase activity. It acts as a primary control compound for evaluating cellular defense models against UV photodamage.
▶ Central MC₄R Agonism Modulate Metabolic Suppression
In verified animal models, MT-2 crosses the blood-brain barrier. It serves as a reliable target verification tool for evaluating appetite suppression pathways and energy expenditure mechanics.
Precise Intracellular Cascade Steps:
Receptor Binding Initiation: Binds to extracellular cell surface MCRs.
Intracellular Signal Amplification: Elevates intracellular cAMP levels.
Protein Kinase Cascade: Activates Protein Kinase A (PKA).
Downstream Gene Regulation: Initiates transcription of tyrosinase genes.
4. Logistics and Cold-Chain Protocols
To maintain strict structural conformity, Shaanxi Sunrise Pharma requires long-term storage of MT-2 at -20℃ in a sealed, dark, and moisture-controlled environment.
All bulk shipments are managed via monitored dry ice cold-chain logistics, adhering fully to UN3373 biological substance transport protocols.
References:
Hadley, M. E., et al. (1996). Pharmaceutical Biotechnology, 8, 147-159.
Dorr, R. T., et al. (1996). Life Sciences, 58(20), 1777-1784.
International Council for Harmonisation (ICH). (2026). Q7 GMP Guidance.
Shaanxi Sunrise Pharmaceutical Quality Control Center. (2026). Internal Report.
